INS and type 1 diabetes mellitus: As a matter of fact, the results of this work have been used to support and inform the design of a clinical trial, for example, time of dosing, glucose target, and titration rule, comparing insulin Gla-300 versus Deg-100 in patients with T1D using a CGM-based metric as a clinical endpoint (NCT04075513).